Text and Data Mining valid from 2019-05-01
Received: 6 November 2018
Accepted: 22 April 2019
First Online: 22 May 2019
Compliance with ethical standards
: All experimental protocols were consistent with the National Institutes of Health Guide for the Care and Use of Laboratory Animals, Eighth Edition (The National Academies Press CitationRef removed), and the Institutional Animal Care and Use Committee at the University of Colorado Boulder approved all procedures. This work was covered under CU Boulder IACUC Protocol Numbers 2134-14MAY2018 and 2361-14MAY2018-DT. The research described here was conducted in compliance with The ARRIVE Guidelines: Animal research: reporting of in vivo experiments, originally published in PLOS Biology, June 2010 (Kilkenny and Altman CitationRef removed).
: Christopher A. Lowry serves on the Scientific Advisory Board of Immodulon Therapeutics Ltd. Dr. Robin Dowell is a founder and scientific advisor of Arpeggio Biosciences.